Clinical Trials Directory

Trials / Completed

CompletedNCT01817556

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

A Multicenter, Active-controlled, Randomized, Double-blind Paralleled-group Clinical Trial to Evaluate the Efficacy of 4-week Treatment With Stillen Tab. in Patients With Acute or Chronic Gastritis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
258 (actual)
Sponsor
Dong-A ST Co., Ltd. · Industry
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients with acute or chronic gastritis. Subject will receive Stillen tab or Mucosta tab., three times a day for four weeks.

Conditions

Interventions

TypeNameDescription
DRUGStillen Tab.
DRUGMucosta Tab.

Timeline

Start date
2012-10-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2013-03-25
Last updated
2021-04-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01817556. Inclusion in this directory is not an endorsement.